MedTrace Logo

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

NCT03865888 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-05-22

No results posted yet for this study

Summary

Evaluation of the effect of topical application of Tacrolimus 0.03% (FK506) eye drops versus Cyclosporine 0.05% eye drops in treatment of dry eye in Secondary Sjogren Syndrome.

Conditions

  • Dry Eye
  • Sjogren Syndrome

Interventions

DRUG

Cyclosporins

Cyclosporins eye drops to be administered in dry eyes

DRUG

Tacrolimus

Tacrolimus eye drops to be administered in dry eyes

Sponsors & Collaborators

  • Pavly Moawd

    lead OTHER

Principal Investigators

  • Omar El Zawahry · Cairo University

  • Gaafar Ragab · Cairo University

  • Rehab Shamma · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-02-01
Completion
2019-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03865888 on ClinicalTrials.gov